NCT05329714Recruiting
PVRI GoDeep Global Deep Phenotyping Meta-Registry for Pulmonary Hypertension
PVRI Global Deep Phenotyping Meta-Registry for Pulmonary Hypertension
Source: ClinicalTrials.gov · Last updated 4 Apr 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
PVRI-GoDeep is a PH Meta-Registry, run under the umbrella of the Pulmonary Vascular Research Institute (PVRI). It merges anonymized PH patient related data from various local registries around the world run under the responsibility of PVRI members. It will be operated under the auspices of the University of Giessen/Giessen PH center. Combining deep phenotyping with worldwide outreach, PVRI-GoDeep aims to offer insights into specific geographical and ethnical profiles of PH, to deepen the epidemiological, clinical and molecular understanding of this disease and to promote strategies for improved individualized treatment of PH patients.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 40000 (estimated)
- First submitted
- 14 Mar 2022
- Start date
- 30 Jan 2020
- Primary completion date
- 30 Jan 2050
- Lead sponsor
- University of Giessen
- NCT number
- NCT05329714
What you commit to
- Study type: Observational
- Planned participants: 40000
- From 30 Jan 2020 to the primary completion date, 30 Jan 2050
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- none
Who the study is looking for
- Clinical Diagnosis of Pulmonary Hypertension
Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Giessen PH Center Coordinator of this site? Confirm its status | Giessen | Germany | Recruiting |
Related publications
This page is information, not medical advice. Discuss any trial with your doctor.